Hepatic microbiome in healthy lean and obese humans

Younossi, 2018, Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention, Nat Rev Gastroenterol Hepatol, 15, 11, 10.1038/nrgastro.2017.109 Wong, 2015, Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States, Gastroenterology, 148, 547, 10.1053/j.gastro.2014.11.039 Lindenmeyer, 2018, The natural history of nonalcoholic fatty liver disease—an evolving view, Clin Liver Dis, 22, 11, 10.1016/j.cld.2017.08.003 Zoller, 2016, Nonalcoholic fatty liver disease and hepatocellular carcinoma, Metabolism, 65, 1151, 10.1016/j.metabol.2016.01.010 Friedman, 2018, Mechanisms of NAFLD development and therapeutic strategies, Nat Med, 24, 908, 10.1038/s41591-018-0104-9 Kim, 2018, Nonalcoholic fatty liver disease and metabolic syndrome, Clin Liver Dis, 22, 133, 10.1016/j.cld.2017.08.010 Abu-Shanab, 2010, The role of the gut microbiota in nonalcoholic fatty liver disease, Nat Rev Gastroenterol Hepatol, 7, 691, 10.1038/nrgastro.2010.172 Ley, 2006, Microbial ecology: human gut microbes associated with obesity, Nature, 444, 1022, 10.1038/4441022a Turnbaugh, 2006, An obesity-associated gut microbiome with increased capacity for energy harvest, Nature, 444, 1027, 10.1038/nature05414 Brun, 2007, Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis, Am J Physiol Gastrointest Liver Physiol, 292, G518, 10.1152/ajpgi.00024.2006 Pendyala, 2012, A high-fat diet is associated with endotoxemia that originates from the gut, Gastroenterology, 142, 10.1053/j.gastro.2012.01.034 Henao-Mejia, 2012, Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity, Nature, 482, 179, 10.1038/nature10809 Seki, 2007, TLR4 enhances TGF-β signaling and hepatic fibrosis, Nat Med, 13, 1324, 10.1038/nm1663 Leung, 2016, The role of the gut microbiota in NAFLD, Nat Rev Gastroenterol Hepatol, 13, 412, 10.1038/nrgastro.2016.85 Tilg, 2016, Gut microbiome and liver diseases, Gut, 65, 2035, 10.1136/gutjnl-2016-312729 Seki, 2012, Role of innate immunity and the microbiota in liver fibrosis: crosstalk between the liver and gut, J Physiol, 590, 447, 10.1113/jphysiol.2011.219691 De Minicis, 2014, Dysbiosis contributes to fibrogenesis in the course of chronic liver injury in mice, Hepatology, 59, 1738, 10.1002/hep.26695 Païssé, 2016, Comprehensive description of blood microbiome from healthy donors assessed by 16S targeted metagenomic sequencing, Transfusion (Paris), 56, 1138, 10.1111/trf.13477 Lelouvier, 2016, Changes in blood microbiota profiles associated with liver fibrosis in obese patients: a pilot analysis, Hepatology, 64, 2015, 10.1002/hep.28829 Balmer, 2014, The liver may act as a firewall mediating mutualism between the host and its gut commensal microbiota, Sci Transl Med, 6, 237ra66, 10.1126/scitranslmed.3008618 Schierwagen, 2019, Circulating microbiome in blood of different circulatory compartments, Gut, 68, 578, 10.1136/gutjnl-2018-316227 Lluch, 2015, The characterization of novel tissue microbiota using an optimized 16S metagenomic sequencing pipeline, PLoS One, 10, 10.1371/journal.pone.0142334 Schierwagen, 2020, Trust is good, control is better: technical considerations in blood microbiome analysis, Gut, 69, 1362, 10.1136/gutjnl-2019-319123 Anhê, 2020, Type 2 diabetes influences bacterial tissue compartmentalisation in human obesity, Nat Metab, 2, 233, 10.1038/s42255-020-0178-9 Suppli, 2020, Glucagon resistance at the level of amino acid turnover in obese subjects with hepatic steatosis, Diabetes, 69, 1090, 10.2337/db19-0715 Suppli, 2019, Hepatic transcriptome signatures in patients with varying degrees of nonalcoholic fatty liver disease compared with healthy normal-weight individuals, Am J Physiol Gastrointest Liver Physiol, 316, G462, 10.1152/ajpgi.00358.2018 Eriksen, 2019, Non-alcoholic fatty liver disease alters expression of genes governing hepatic nitrogen conversion, Liver Int, 39, 2094, 10.1111/liv.14205 Escudié, 2018, FROGS: find, rapidly, OTUs with galaxy solution, Bioinformatics, 34, 1287, 10.1093/bioinformatics/btx791 Stewart, 2012, Growing unculturable bacteria, J Bacteriol, 194, 4151, 10.1128/JB.00345-12 Sookoian, 2020, Intrahepatic bacterial metataxonomic signature in non-alcoholic fatty liver disease, Gut, 69, 1483, 10.1136/gutjnl-2019-318811 Marchesini, 2003, Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome, Hepatology, 37, 917, 10.1053/jhep.2003.50161 Miele, 2009, Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease, Hepatology, 49, 1877, 10.1002/hep.22848 Volynets, 2012, Nutrition, intestinal permeability, and blood ethanol levels are altered in patients with nonalcoholic fatty liver disease (NAFLD), Dig Dis Sci, 57, 1932, 10.1007/s10620-012-2112-9 Turnbaugh, 2009, A core gut microbiome in obese and lean twins, Nature, 457, 480, 10.1038/nature07540 Le Chatelier, 2013, Richness of human gut microbiome correlates with metabolic markers, Nature, 500, 541, 10.1038/nature12506 Rivera, 2007, Toll-like receptor-4 signaling and Kupffer cells play pivotal roles in the pathogenesis of non-alcoholic steatohepatitis, J Hepatol, 47, 571, 10.1016/j.jhep.2007.04.019 Bellot, 2010, Bacterial DNA translocation is associated with systemic circulatory abnormalities and intrahepatic endothelial dysfunction in patients with cirrhosis, Hepatology, 52, 2044, 10.1002/hep.23918 Amar, 2013, Blood microbiota dysbiosis is associated with the onset of cardiovascular events in a large general population: the D.E.S.I.R. study, PloS One, 8, 10.1371/journal.pone.0054461